Unlike some medications associated with false readings in urine drug tests, such as certain antidepressants and SGLT2 inhibitors, tirzepatide and its counterpart, semaglutide (Ozempic), lack documented instances of causing false positives
Medical weight loss provides a safe, effective way to manage chronic weight issues and health concerns
The approval was based on data from the FIBRONEER-IPF trial, where the drug showed: A smaller decline in Forced Vital Capacity (FVC) over 52 weeks versus placebo Benefits visible as early as week 2 A favourable safety profile A huge milestone for patients living with IPF
Drinking enough water, especially if you experience side effects like diarrhea, can help maintain balanced potassium levels
Genetics of type 2 diabetes: past, present, and future